Blackstone Life Sciences Announces A $455M Collaboration With Boston ScientificTo Co-Fund The Development Of The VITALYST Temporary Percutaneous Transvalvular Circulatory Support System Program
Share
Why It Matters
Blackstone and Boston Scientific teamed up to pay for a new heart device together. When big companies share the cost of new inventions, it shows they believe in the project's future.
This read is generated by AI from raw market data and is for education only. It is not financial advice, not a signal, and not a recommendation to buy or sell.
Tickers in Play
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only. Not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.